Ninlaro (ixazomib citrate)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ninlaro (ixazomib citrate), covering 2022-07-05 to 2024-06-13. Get the full timeline:
Most recent: Clinical Trial Update: Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib [Phase 2]